Cerbocon Pharmaceutical Private Limited
About Cerbocon Pharmaceutical Private Limited
Data last updated:
Cerbocon Pharmaceutical Private Limited is a private limited company based in Moradabad, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 July 2024.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U46497UP2024PTC206597.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajesh Kumar Gupta and Yash Kumar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Moradabad, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.86 Lakh. For the same year it recorded a net loss of ₹78,914 (net margin -6.1%) and EBITDA of -₹78,914 (EBITDA margin -6.1%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address148 Near Shiv Shakti, Mandir Linepar, Moradabad, Uttar Pradesh, India – 244001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Cerbocon Pharmaceutical Private Limited FY 2025 filings available
Cerbocon Pharmaceutical Private Limited reported revenue of ₹12.86 Lakh for FY 2025.
Financial Statement Summary of Cerbocon Pharmaceutical Private Limited
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | -₹78,914 |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | -₹78,914 |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Cerbocon Pharmaceutical Private Limited
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | -6.1% |
| Net Profit Margin | -6.1% |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cerbocon Pharmaceutical are in the company report.
Financial statements from FY 2025
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Cerbocon Pharmaceutical Private Limited
Cerbocon Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Gupta | Director | 22 Jul 2024 | 2 Years 2 Months | Current |
| Yash Kumar Gupta | Director | 22 Jul 2024 | 2 Years 2 Months | Current |
Charges & Borrowings of Cerbocon Pharmaceutical Private Limited
Cerbocon Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Cerbocon Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Cerbocon Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Cerbocon Pharmaceutical Private Limited
Cerbocon Pharmaceutical Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Rajesh Kumar Gupta was appointed as Director on 22 Jul 2024.
Credit Ratings, Litigation & Regulatory Alerts for Cerbocon Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cerbocon Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cerbocon Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cerbocon Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cerbocon Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cerbocon Pharmaceutical Private Limited
Cerbocon Pharmaceutical is an active private limited company based in Moradabad, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 July 2024 (2+ years old) and is registered under CIN U46497UP2024PTC206597.
Cerbocon Pharmaceutical reported revenue of ₹12.86 Lakh for FY 2025.
Cerbocon Pharmaceutical has 2 current directors:
- Rajesh Kumar Gupta - Director
- Yash Kumar Gupta - Director
Cerbocon Pharmaceutical reported a net loss of ₹78,914 (net margin -6.1%) and EBITDA of -₹78,914 (EBITDA margin -6.1%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Cerbocon Pharmaceutical is U46497UP2024PTC206597. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cerbocon Pharmaceutical was incorporated on 22 July 2024, making it 2+ years old. It is registered with the Registrar of Companies, Kanpur.
Rajesh Kumar Gupta was appointed as Director on 22 Jul 2024. Yash Kumar Gupta was appointed as Director on 22 Jul 2024.
The registered office of Cerbocon Pharmaceutical is at 148 Near Shiv Shakti, Mandir Linepar, Moradabad, Uttar Pradesh, India – 244001.
Cerbocon Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
Cerbocon Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.